Paul Goncharoff

Paul GoncharoffPaul Goncharoff, Senior Adviser, Moscow

A native New Yorker, Paul has lived & worked in Asia, MENA, Europe, and is based full time in Russia. Paul became heavily involved in the economic opportunities and dynamics of Russia in the late 1980's as executive, while introducing and applying best global standards where and when applicable.

Has managed, developed, integrated and advised start-up and established companies connected with Russia/FSU markets such as AIG, Tecnomatix NV, YUKOS, Lynx Oil & Gas, Petropavlovsk PLC, Axia/Allianz and more. Has served as strategic advisor and Board Member/Non Executive Director (NED) within General Management, Strategic Planning, Sales, Business Development, R&D, Operations, Risk Management, and Investor Relations.

Executive management of multicultural businesses, operations and staff in urban, regional and remote areas of Russia/FSU.

Has earned a strong reputation in the Russia/CIS business arena for successfully introducing and supporting common-sense governance best practices, enhancing business value, managing risk, defining mission, purpose, profitability & transparency.

Our Articles

New Russian law tightens the procedure for putting medicines on the market and complicates ending distribution agreements

From 29 November 2019, medicines for human use will no longer be put on the market based on declarations of compliance and certification. More complex quality control requirements will be introduced. Pharmaceutical companies will have to submit documents on the quality of each batch of medicines to the Russian pharmaceutical regulator (Roszdravnadzor), conduct tests of the first three batches produced or imported and periodically submit test reports of batches of any medicine put into circulation.

Social Media

@Albion_Overseas

    Our Events

    © 1996 - 2014 Albion Overseas Ltd  Registration Number: 03282937 VAT Number: 685109616 Registered Office: Riverside House, River Lawn Road, Tonbridge, Kent, TN9 1EP, UK